NCT05679349 Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
| NCT ID | NCT05679349 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ronald Myers |
| Condition | Lung Carcinoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 822 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2027-02-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 822 participants in total. It began in 2024-04-01 with a primary completion date of 2027-02-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial tests how well providing education improves screening for lung cancer in patients with a history of smoking. Screenings may help doctors find lung cancer sooner when it may be easier to treat. Education and counseling may be an effective method to help providers and patients learn about lung cancer screening. Providing education and decision counseling to providers and patients may increase lung cancer screening.
Eligibility Criteria
Inclusion Criteria: * PRACTICE LEVEL: * Primary care practice (family medicine, geriatrics, internal medicine) in one of the 4 participating health systems * Practice using the main electronic medical record (EMR) of each system, in order to run appropriate patient recruitment reports * Practice with at least 50% of practice providers (physicians and advanced care providers) consenting to participate * PATIENT LEVEL: * Have an office or telemedicine established patient visit scheduled with a primary care provider in one of the participating practices within next 14 to 25 days * 50 to 77 years of age * Have at least a 20-pack-year smoking history (based on self-report at baseline eligibility assessment) * Currently smoke or have quit smoking within the past 15 years (based on self-report at baseline eligibility assessment) * Able to communicate in English or Spanish (determined at baseline eligibility assessment) Exclusion Criteria: * PATIENT OUTREACH: * Any lung computed tomography (CT) or low-dose computed tomography (LDCT) scan in the past 11 months, current procedural terminology (CPT) Codes are as follows * G0297 - LDCT screening * 71250 - CT w/o contrast * 71260 - CT w/ contrast * 71270 - CT with and w/o contrast * 71275 - CT angiography chest * 78815 - Positron emission tomography computed tomography (PET CT) skull base to mid-thigh * 78816 - PET CT whole body * Prior history of lung cancer (The patient's problem list includes a problem with an international classification of diseases (ICD10) code of "Z85.118" or one beginning with "C34.", or by self-report at baseline eligibility assessment) * Recent hospitalization (Admission date within the last 60 days listed in electronic health record (EHR), or by self-report at baseline eligibility assessment) * Dementia (diagnosis codes F03.90 or F03.91) in EHR
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05679349 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 77 Years, studying Lung Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05679349 currently recruiting?
Yes, NCT05679349 is actively recruiting participants. Contact the research team at ronald.myers@jefferson.edu for enrollment information.
Where is the NCT05679349 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT05679349 clinical trial?
NCT05679349 is sponsored by Ronald Myers. The trial plans to enroll 822 participants.